(Q28166923)

English

Rhabdomyolysis and renal failure associated with gemfibrozil monotherapy

scientific article (publication date: February 2004)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Rhabdomyolysis and renal failure associated with gemfibrozil monotherapy (English)

0 references

0 references

1 reference

Richard D Layne

1

0 references

Aasim S Sehbai

series ordinal

2

0 references

Linda J Stark

series ordinal

3

0 references

language of work or name

English

0 references

publication date

February 2004

0 references

published in

Annals of Pharmacotherapy

0 references

volume

38

0 references

issue

2

0 references

page(s)

232-4

0 references

cites work

Risk for myopathy with statin therapy in high-risk patients.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1D282

retrieved

21 January 2018

Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care setting

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1D282

retrieved

21 January 2018

Statin-associated myopathy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1D282

retrieved

21 January 2018

Myopathy and rhabdomyolysis with lipid-lowering drugs

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1D282

retrieved

21 January 2018

ACC/AHA/NHLBI clinical advisory on the use and safety of statins

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1D282

retrieved

21 January 2018

Acute Muscular Syndrome Associated with Administration of Clofibrate

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1D282

retrieved

21 January 2018

Rhabdomyolysis associated with gemfibrozil-colchicine therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1D282

retrieved

21 January 2018

Lipid-lowering drugs: are adverse effects predictable and reversible?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1D282

retrieved

21 January 2018

Acute renal failure: a practical update

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1D282

retrieved

21 January 2018

Catastrophic medical events with exhaustive exercise: "white collar rhabdomyolysis".

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1D282

retrieved

21 January 2018

A method for estimating the probability of adverse drug reactions

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1345%2FAPH.1D282

retrieved

21 January 2018

Identifiers

DOI

10.1345/APH.1D282

0 references

PubMed publication ID

14742756

0 references

(Q28166923)

Rhabdomyolysis and renal failure associated with gemfibrozil monotherapy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)